Generic selectors
Exact matches only
Search in title
Search in content
Get in touch

Health

Health is critical to our wellbeing as individuals, plays a key role in societal and economic advances, and presents many opportunities for environmental impact. Innovations in health & care allow us to alleviate suffering, increase quality of life and life expectancy, and manage the needs of a changing and ageing population.

Health

The “Health sector” which delivers these innovations is diverse and covers a wide range of business activities. KTN covers the whole sector by focusing on the broad sub sectors of Medicines, Medical Technology and Digital Health. The logic behind this focus is that each of the sub-sectors is a significant sector in its own right and has distinct characteristics. The Health team at KTN has considerable experience of working in these sub-sectors and of driving cross-sector working to facilitate positive change.

KTN’s Medimap provides a dynamic representation of the UK’s end-to-end medicines supply chain covering organisations involved in the discovery, development and manufacture of medicines, as well as those supporting the sector.

Digital Health & Care

The digital health and care sub-sector is characterised by a large number of small companies developing technology across the health spectrum.

Medicines

The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME “biotech” companies.

MedTech

Medical technologies touch all of our lives – from pregnancy testing and ultrasound scans before birth; through wound care products for childhood injuries; to diagnostic imaging systems and therapeutic implants for disease in adults.

Medimap: End-to-end medicines supply chain map

Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.

AI in Health

The application of Artificial Intelligence and machine learning to the field of health represents a major opportunity for the UK. AI is a powerful tool that can be applied across industry sectors to solve specific challenges. The application of these tools in Health requires a mutual understanding between the AI and Health communities.

Microbiome

The Microbiome Innovation Network (formerly SIG) aims to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia.

Neurotechnology

From bioelectronic medicine that treat chronic diseases, to brain-computer interfaces that help stroke rehabilitation, neurotechnology will play an increasingly important role in meeting some of the challenges of an ageing society.

Funding Opportunities

Medicines and Diagnostics Manufacturing Transformation Fund

New £20 million fund to grow UK life sciences manufacturing opens for applications

Opens: 07/04/2021 Closes: 30/06/2021

Explore Further

Zinc Venture Builder 2021

The Zinc Venture Builder programme is a full time, 12 month programme to build new companies that tackle the biggest social challenges in the developed world. 2021’s challenge is “to ensure that every child and young person can develop and maintain good mental and emotional health”.

Opens: 17/05/2021 Closes: 25/06/2021

Explore Further

Biomedical catalyst 2021: early and late stage awards

UK registered organisations can apply for a share of up to £18 million to develop innovative healthcare products, technologies, and processes.

Opens: 07/06/2021 Closes: 26/08/2021

Explore Further

Events

Thu
15
Oct
2020

Emerging & Novel Sensing Technologies for Precision Medicine & Digital Health

10.00 - 12.00 | Online

Watch Now

Wed
2
Dec
2020

What is 5G and its role in the health sector and panel session

10.30 - 11.30 | Online

Watch Now

Mon
9
Nov
2020

Industrial Strategy Challenge Fund for Healthy Ageing Showcase

13.00 - 17.00 | Online

Watch Now

News

08.04.2021

Horizon Europe Cluster 1: Health

Horizon Europe is the next European Funding Framework Programme following on from its predecessor Horizon 2020. It will run for seven years from 2021 to 2027. The total budget set for the programme is €95.5 billion. There are six Clusters under Pillar 2: Global Challenges and European Industrial Competitiveness. Health is Cluster 1.

Read more

20.05.2021

How AI is vastly improving cancer treatment on a patient-by-patient basis

AI has already revolutionised cancer diagnostic capabilities, now it’s revolutionising treatment as well. Laura Towart, founder and CEO, explains how AI and robotics enable Vivan Therapeutics’ approach to cancer.

Read more

Programmes related to Health

View all our programmes

Medimap: End-to-end medicines supply chain map

Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.

Learn More

Neurotechnology Landscape

Neurotechnology is the application of electronics and engineering to the human nervous system and ranges from the measurement of the whole brain through technologies such as electroencephalography to the stimulation of a single nerve using bioelectronic medicines.

Learn More